Maury Raycroft
Stock Analyst at Jefferies
(4.40)
# 1,185
Out of 4,792 analysts
237
Total ratings
42.9%
Success rate
11.1%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANL Adlai Nortye Group | Initiated Coverage: Buy | $31 | $15.09 | +105.43% | 1 | Sep 10, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $129 → $28 | $14.40 | +94.44% | 15 | Sep 3, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $47 → $10 | $1.96 | +410.20% | 2 | Aug 6, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $44 → $42 | $23.54 | +78.42% | 7 | Aug 5, 2026 | |
| KPTI Karyopharm Therapeutics | Reiterated: Buy | $35 → $11 | $1.62 | +579.01% | 7 | Jul 31, 2026 | |
| ERAS Erasca | Rated: Buy | $21 → $24 | $16.03 | +49.72% | 3 | Jul 14, 2026 | |
| COAG Hemab Therapeutics Holdings | Reiterated: Buy | $39 → $47 | $39.88 | +17.85% | 3 | Jul 13, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $27 → $60 | $23.37 | +156.74% | 3 | Jun 26, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $132 | $103.28 | +27.81% | 6 | Jun 15, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $53 → $33 | $8.24 | +300.49% | 7 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.83 | +213.32% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $2.05 | +339.02% | 4 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $52 | $37.45 | +38.85% | 2 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 → $56 | $32.87 | +70.37% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $6.69 | +124.22% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $1.77 | +1,481.92% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $4.17 | +379.62% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $16.11 | +30.35% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.49 | +7.38% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $549 | $247.51 | +121.81% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $8.29 | +80.94% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $24.37 | +68.24% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $67.51 | n/a | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $79 | $85.49 | n/a | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $23 | $12.07 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $1.21 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.16 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $9 | $3.35 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $15 | $9.07 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $1.5 | $0.1554 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.2446 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $1.16 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $20 | $0.0001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $28.00 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.8026 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $33.60 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $82.76 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $52.26 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $0.7668 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $109 | $11.93 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $25 | $9.89 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $86 | $24.17 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.24 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $58.80 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.48 | n/a | 2 | May 22, 2018 |
Adlai Nortye Group
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $15.09
Upside: +105.43%
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Buy
Price Target: $129 → $28
Current: $14.40
Upside: +94.44%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $47 → $10
Current: $1.96
Upside: +410.20%
Tyra Biosciences
Aug 5, 2026
Reiterated: Buy
Price Target: $44 → $42
Current: $23.54
Upside: +78.42%
Karyopharm Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $35 → $11
Current: $1.62
Upside: +579.01%
Erasca
Jul 14, 2026
Rated: Buy
Price Target: $21 → $24
Current: $16.03
Upside: +49.72%
Hemab Therapeutics Holdings
Jul 13, 2026
Reiterated: Buy
Price Target: $39 → $47
Current: $39.88
Upside: +17.85%
Tango Therapeutics
Jun 26, 2026
Upgraded: Buy
Price Target: $27 → $60
Current: $23.37
Upside: +156.74%
Dianthus Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: $132
Current: $103.28
Upside: +27.81%
Corbus Pharmaceuticals Holdings
May 12, 2026
Reiterated: Buy
Price Target: $53 → $33
Current: $8.24
Upside: +300.49%
Apr 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.83
Upside: +213.32%
Apr 27, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $2.05
Upside: +339.02%
Apr 5, 2026
Reiterated: Buy
Price Target: $14 → $52
Current: $37.45
Upside: +38.85%
Mar 26, 2026
Rated: Buy
Price Target: $39 → $56
Current: $32.87
Upside: +70.37%
Mar 23, 2026
Reiterated: Buy
Price Target: $14 → $15
Current: $6.69
Upside: +124.22%
Feb 25, 2026
Reiterated: Buy
Price Target: $28
Current: $1.77
Upside: +1,481.92%
Dec 8, 2025
Reiterated: Buy
Price Target: $15 → $20
Current: $4.17
Upside: +379.62%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $16.11
Upside: +30.35%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.49
Upside: +7.38%
Oct 30, 2025
Reiterated: Buy
Price Target: $384 → $549
Current: $247.51
Upside: +121.81%
Oct 14, 2025
Reiterated: Buy
Price Target: $14 → $15
Current: $8.29
Upside: +80.94%
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $24.37
Upside: +68.24%
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $67.51
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $33 → $79
Current: $85.49
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $40 → $23
Current: $12.07
Upside: n/a
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $1.21
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $8
Current: $5.16
Upside: n/a
May 19, 2025
Reiterated: Buy
Price Target: $15 → $9
Current: $3.35
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $7 → $15
Current: $9.07
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $2 → $1.5
Current: $0.1554
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.2446
Upside: n/a
Nov 13, 2024
Rated: Buy
Price Target: $21
Current: $1.16
Upside: n/a
Apr 4, 2024
Reiterated: Buy
Price Target: $10 → $20
Current: $0.0001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $28.00
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $0.8026
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $33.60
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $75
Current: $82.76
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $52.26
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $0.7668
Upside: n/a
Jun 22, 2021
Reiterated: Buy
Price Target: $37 → $109
Current: $11.93
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $14 → $25
Current: $9.89
Upside: n/a
Jul 29, 2020
Reiterated: Buy
Price Target: $34 → $86
Current: $24.17
Upside: n/a
May 18, 2020
Reiterated: Buy
Price Target: $25
Current: $7.24
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $58.80
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $5.48
Upside: n/a